omeprazole has been researched along with alprostadil in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (47.62) | 18.7374 |
1990's | 4 (19.05) | 18.2507 |
2000's | 2 (9.52) | 29.6817 |
2010's | 5 (23.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, BW; Cho, CH; Hui, WM; Lam, SK; Luk, CT | 1 |
Earnest, DL | 1 |
Fields, JZ; Haydek, JM; Keshavarzian, A; Stinneford, JG; Zepeda, DO | 1 |
Amouzadeh, HR; MacAllister, CC; Sangiah, S | 1 |
Mahachai, V; Thomson, AB | 1 |
Dammann, HG; Müller, P; Simon, B | 2 |
Gugler, R | 2 |
Dammann, HG; Kommerell, B; Müller, P; Simon, B | 1 |
McColl, KE | 1 |
Holm, L | 1 |
Haag, K; Knauf, H | 1 |
Harada, T | 1 |
Guo, CB; Jin, XQ; Kang, Q; Li, YC; Pu, CL; Yan, LN; Zhang, MM | 1 |
3 review(s) available for omeprazole and alprostadil
Article | Year |
---|---|
Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Topics: Alprostadil; Antacids; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Enprostil; Famotidine; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Prostaglandins E, Synthetic; Ranitidine; Sucralfate; Thiazoles | 1987 |
Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
Topics: Alprostadil; Animals; Anti-Ulcer Agents; Duodenal Ulcer; Enprostil; Gastric Juice; Gastrins; Humans; Misoprostol; Omeprazole; Prostaglandins E, Synthetic; Stomach Ulcer | 1988 |
[New therapy of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alprostadil; Anti-Ulcer Agents; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Recurrence | 1995 |
3 trial(s) available for omeprazole and alprostadil
Article | Year |
---|---|
[Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Topics: Adult; Alprostadil; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Gastric Mucosa; Gastroscopy; Humans; Misoprostol; Omeprazole; Prostaglandins E; Prostaglandins, Synthetic; Random Allocation; Ranitidine; Rioprostil; Stomach Ulcer | 1986 |
[Drug therapy of peptic ulcer. What is coming up?].
Topics: Alprostadil; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Enprostil; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Prostaglandins E, Synthetic; Ranitidine | 1987 |
[Stomach tolerance of nonsteroidal antirheumatic drugs: comparative endoscopic study].
Topics: Adult; Alprostadil; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Gastroscopy; Humans; Indomethacin; Misoprostol; Omeprazole; Prostaglandins E; Ranitidine; Rioprostil; Stomach Ulcer | 1987 |
15 other study(ies) available for omeprazole and alprostadil
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Role of gastric mucosal blood flow in cytoprotection.
Topics: Alprostadil; Animals; Anti-Ulcer Agents; Cimetidine; Ethanol; Gastric Mucosa; Lasers; Male; Misoprostol; Omeprazole; Rats; Rats, Inbred Strains; Regional Blood Flow; Stomach Ulcer; Sucralfate | 1991 |
Controlling gastric pH: the impact of newer agents on the critically ill patient.
Topics: Alprostadil; Anti-Ulcer Agents; Critical Care; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Misoprostol; Omeprazole; Parietal Cells, Gastric; Pirenzepine; Proglumide; Risk Factors; Somatostatin; Stomach Ulcer; Stress, Physiological | 1990 |
Gastroduodenal ulcers in rats induced by 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): requirement for gastric acid secretion and the role of prostaglandins.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alprostadil; Animals; Atropine; Duodenal Ulcer; Female; Gastric Acid; Injections, Subcutaneous; Misoprostol; Omeprazole; Prostaglandins; Rats; Rats, Inbred F344; Stomach Ulcer; Time Factors | 1990 |
Effects of misoprostol and omeprazole on basal gastric pH and free acid content in horses.
Topics: Administration, Oral; Alprostadil; Animals; Anti-Ulcer Agents; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Horses; Hydrogen-Ion Concentration; Injections, Intravenous; Misoprostol; Omeprazole; Random Allocation | 1989 |
[New developments in ulcer therapy: famotidine, omeprazole misoprostol].
Topics: Alprostadil; Anti-Ulcer Agents; Famotidine; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Thiazoles | 1986 |
[Peptic ulcer. New H2 blockers, prostaglandins, benzimidazoles].
Topics: Alprostadil; Anti-Ulcer Agents; Famotidine; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Thiazoles | 1987 |
Gastric mucosal blood flow and mucosal protection.
Topics: 16,16-Dimethylprostaglandin E2; Alprostadil; Animals; Dinoprostone; Gastric Mucosa; Male; Mucus; Neutrophils; Omeprazole; Rats; Rats, Inbred Strains | 1988 |
Modelling of colonic Cl- and K+ transport under resting and secreting conditions.
Topics: Alprostadil; Animals; Biological Transport; Chlorides; Colon; Diuretics; Indomethacin; Intestinal Mucosa; Male; Membrane Potentials; Models, Biological; Omeprazole; Potassium; Rats; Rats, Inbred Strains | 1986 |
Early postoperative care of liver transplantation for infants with biliary atresia during pediatric intensive care unit stay.
Topics: Alprostadil; Bacterial Infections; Biliary Atresia; Body Weight; Cardiotonic Agents; Dobutamine; Dopamine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Infant; Intensive Care Units, Pediatric; Length of Stay; Liver Transplantation; Omeprazole; Organ Size; Postoperative Care; Postoperative Complications | 2010 |